These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

495 related items for PubMed ID: 14512399

  • 1. Venous thromboembolism associated with long-term use of central venous catheters in cancer patients.
    Verso M, Agnelli G.
    J Clin Oncol; 2003 Oct 01; 21(19):3665-75. PubMed ID: 14512399
    [Abstract] [Full Text] [Related]

  • 2. Therapy Insight: venous-catheter-related thrombosis in cancer patients.
    Agnelli G, Verso M.
    Nat Clin Pract Oncol; 2006 Apr 01; 3(4):214-22. PubMed ID: 16596145
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Venous thromboembolism associated with long-term use of central venous catheters in cancer patients].
    Debourdeau P, Zammit C, Pavic M, Bensaid B, Farge-Bancel D.
    Rev Med Interne; 2007 Jul 01; 28(7):471-83. PubMed ID: 17561314
    [Abstract] [Full Text] [Related]

  • 6. Venous thromboembolism and cancer: prevention and therapy.
    Lee AY.
    Vnitr Lek; 2006 Mar 01; 52 Suppl 1():127-8, 130-1. PubMed ID: 16637461
    [Abstract] [Full Text] [Related]

  • 7. Lessons from French National Guidelines on the treatment of venous thrombosis and central venous catheter thrombosis in cancer patients.
    Farge D, Durant C, Villiers S, Long A, Mahr A, Marty M, Debourdeau P, Groupe Francophone Thrombose et Cancer (GFTC).
    Thromb Res; 2010 Apr 01; 125 Suppl 2():S108-16. PubMed ID: 20433988
    [Abstract] [Full Text] [Related]

  • 8. Incidence of thrombotic complications in patients with haematological malignancies with central venous catheters: a prospective multicentre study.
    Cortelezzi A, Moia M, Falanga A, Pogliani EM, Agnelli G, Bonizzoni E, Gussoni G, Barbui T, Mannucci PM, CATHEM Study Group.
    Br J Haematol; 2005 Jun 01; 129(6):811-7. PubMed ID: 15953009
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Prevention and management of central venous catheter occlusion and thrombosis in children with cancer.
    Skinner R, Koller K, McIntosh N, McCarthy A, Pizer B, United Kingdom Children's Cancer Study Group (UKCCSG), Paediatric Oncology Nursing Forum (PONF) Supportive Care Group.
    Pediatr Blood Cancer; 2008 Apr 01; 50(4):826-30. PubMed ID: 17729250
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Infections increase the risk of central venous catheter-related thrombosis in adult acute myeloid leukemia.
    Del Principe MI, Buccisano F, Maurillo L, Venditti D, Cefalo M, Sarlo C, Di Caprio L, Di Veroli A, Nasso D, Ceresoli E, Postorino M, Di Piazza F, Colandrea G, Conti F, Del Poeta G, Amadori S, Venditti A.
    Thromb Res; 2013 Nov 01; 132(5):511-4. PubMed ID: 24090605
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Low-molecular-weight heparin (nadroparin) and very low doses of warfarin in the prevention of upper extremity thrombosis in cancer patients with indwelling long-term central venous catheters: a pilot randomized trial.
    Mismetti P, Mille D, Laporte S, Charlet V, Buchmüller-Cordier A, Jacquin JP, Fournel P, Dutrey-Dupagne C, Decousus H, CIP Study Group.
    Haematologica; 2003 Jan 01; 88(1):67-73. PubMed ID: 12551829
    [Abstract] [Full Text] [Related]

  • 15. The role of low-molecular-weight heparins as supportive care therapy in cancer-associated thrombosis.
    Cunningham RS.
    Semin Oncol; 2006 Apr 01; 33(2 Suppl 4):S17-25; quiz S41-2. PubMed ID: 16638457
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Prophylaxis of catheter-related deep vein thrombosis in cancer patients with low-dose warfarin, low molecular weight heparin, or control: a randomized, controlled, phase III study.
    Lavau-Denes S, Lacroix P, Maubon A, Preux PM, Genet D, Vénat-Bouvet L, Labourey JL, Martin J, Slaouti P, Tubiana-Mathieu N.
    Cancer Chemother Pharmacol; 2013 Jul 01; 72(1):65-73. PubMed ID: 23636449
    [Abstract] [Full Text] [Related]

  • 19. Low-molecular-weight heparin in cancer-associated thrombosis: treatment, secondary prevention, and survival.
    Nishioka J, Goodin S.
    J Oncol Pharm Pract; 2007 Jun 01; 13(2):85-97. PubMed ID: 17873108
    [Abstract] [Full Text] [Related]

  • 20. What is the optimal pharmacological prophylaxis for the prevention of deep-vein thrombosis and pulmonary embolism in patients with acute ischemic stroke?
    Kamphuisen PW, Agnelli G.
    Thromb Res; 2007 Jun 01; 119(3):265-74. PubMed ID: 16674999
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.